Clinical Trial Update: Phase I BP Interferon (IFN) Beta-004 [Phase 1]

View source ↗

Summary

Phase I trial update shows BP Interferon Beta-004 in relapsing-remitting multiple sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• BP Interferon Beta-004 (Interferon beta)

Snippet

Sponsor: Centre Hospitalier Universitaire Vaudois | Conditions: Multiple Sclerosis, Relapsing-Remitting | Phase 1 | Status: COMPLETED